Abstract
The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
| Original language | English |
|---|---|
| Pages (from-to) | 383-386 |
| Number of pages | 4 |
| Journal | Therapeutic Delivery |
| Volume | 1 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2010 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
Cite this
Antiretroviral nanoparticles : An extended drug delivery modality. / Destache, Christopher J.; Goede, Michael; Belgum, Todd.
In: Therapeutic Delivery, Vol. 1, No. 3, 09.2010, p. 383-386.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Antiretroviral nanoparticles
T2 - An extended drug delivery modality
AU - Destache, Christopher J.
AU - Goede, Michael
AU - Belgum, Todd
PY - 2010/9
Y1 - 2010/9
N2 - The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
AB - The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
UR - http://www.scopus.com/inward/record.url?scp=79954505080&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79954505080&partnerID=8YFLogxK
U2 - 10.4155/tde.10.42
DO - 10.4155/tde.10.42
M3 - Article
VL - 1
SP - 383
EP - 386
JO - Therapeutic Delivery
JF - Therapeutic Delivery
SN - 2041-5990
IS - 3
ER -